The carcinogenic potential of RUNX2 overexpression and the possibility that its tumor suppressor functions are dysregulated suggest that the gain and amplification of chromosome 6p12-p21 plays a role in the etiology of osteosarcoma. This evidence concerns the gene CDKN1A and osteosarcoma.